✦ LIBER ✦

A randomized parallel-group dietary study for stages II–IV ovarian cancer survivors

✍ Scribed by Raheem J. Paxton; Celia Garcia-Prieto; Maria Berglund; Mike Hernandez; Richard A. Hajek; Beverly Handy; Jubilee Brown; Lovell A. Jones

Book ID: 113963538
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 336 KB
Volume: 124
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2011.11.031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized phase III trial of chemoimmun

Randomized phase III trial of chemoimmunotherapy in patients with previously untreated stages III and IV suboptimal disease ovarian cancer: A Southwest Oncology Group study

✍ David S. Alberts; Nancy Mason-Liddil; Robert V. O'Toole; Thomas M. Abbott; Richa 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 763 KB

Prognostic factors for high-risk early-s

Prognostic factors for high-risk early-stage epithelial ovarian cancer : A Gynecologic Oncology Group study

✍ John K. Chan; Chunqiao Tian; Bradley J. Monk; Thomas Herzog; Daniel S. Kapp; Jef 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

## Abstract ## BACKGROUND. The purpose was to identify the factors predictive of recurrence and survival in patients with high‐risk (stage I, grade 3; stage IC, stage II, or clear cell) epithelial ovarian cancer after adjuvant therapy. ## METHODS. Data was extracted from patients who underwent p

Phase II trial of vinorelbine for relaps

Phase II trial of vinorelbine for relapsed ovarian cancer: a Southwest Oncology Group study

✍ Mace L. Rothenberg; P.Y. Liu; Sharon Wilczynski; William A. Nahhas; Gaye L. Wina 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 242 KB

Teniposide (VM-26) in patients with adva

Teniposide (VM-26) in patients with advanced refractory ovarian cancer: a phase II study of the Netherlands joint study group for ovarian cancer

✍ van der Burg, M.E.L.; Ten Bokkel Huinink, W.W.; Vriesendorp, R.; van Oosterom, A 📂 Article 📅 1987 🏛 Elsevier Science ⚖ 213 KB

Paclitaxel/carboplatin versus topotecan/

Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III–IV epithelial ovarian cancer a multicenter, randomized study

✍ Giorgio Bolis; Giovanna Scarfone; Francesco Raspagliesi; Giorgia Mangili; Saveri 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 543 KB

Prognostic factors for stage III epithel

Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: A Gynecologic Oncology Group study

✍ L. Landrum; J. Java; C. Mathews; G. Lanneau; L. Copeland; D. Armstrong; J. Walke 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 78 KB